Publication | Open Access
Dominant negative inhibition by fragments of a monomeric enzyme
19
Citations
25
References
1996
Year
Dominant negative inhibition is most commonly seen when a mutant subunit of a multisubunit protein is coexpressed with the wild-type protein so that assembly of a functional oligomer is impaired. By analogy, it should be possible to interfere with the functional assembly of a monomeric enzyme by interfering with the folding pathway. Experiments in vitro by others suggested that fragments of a monomeric enzyme might be exploited for this purpose. We report here dominant negative inhibition of bacterial cell growth by expression of fragments of a tRNA synthetase. Inhibition is fragment-specific, as not all fragments cause inhibition. An inhibitory fragment characterized in more detail forms a specific complex with the intact enzyme in vivo, leading to enzyme inactivation. This fragment also associated stoichiometrically with the full-length enzyme in vitro after denaturation and refolding, and the resulting complex was catalytically inactive. Inhibition therefore appears to arise from an interruption in the folding pathway of the wild-type enzyme, thus suggesting a new strategy to design dominant negative inhibitors of monomeric enzymes.
| Year | Citations | |
|---|---|---|
1991 | 1.1K | |
1992 | 387 | |
1984 | 263 | |
1990 | 218 | |
1991 | 212 | |
1988 | 160 | |
1987 | 156 | |
1992 | 150 | |
1991 | 130 | |
Functional domains of wild-type and mutant p53 proteins involved in transcriptional regulation, transdominant inhibition, and transformation suppression. Tamar Unger, Judy A. Mietz, Martin Scheffner, Molecular and Cellular Biology Functional DomainsMutant P53 ProteinsMolecular RegulationWt P53 FunctionWt P53 | 1993 | 125 |
Page 1
Page 1